Apogee director granted 2,530-share stock award

A director of APOGEE ENTERPRISES, INC. received a 2,530-share stock grant that vests in equal installments over three years.

Available on EDGAR 09/15/2026 - 03:59 PM EDT Accepted by SEC EDGAR 09/15/2026 - 03:59 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

APOGEE ENTERPRISES, INC. (symbol: APOG) is the issuer of record for a Form 4 filing submitted to the SEC. STREICH JULIE K reported acquisition or exercise transactions in this Form 4 filing.

APOGEE ENTERPRISES, INC. (APOG) reported that director Julie K. Streich received a grant of 2,530 shares of common stock on September 11, 2026. The award was received at no cash cost to her and represents direct ownership of 2,530 shares after the transaction.

The shares vest over a three-year period, with one-third scheduled to vest on each of September 11, 2027, September 11, 2028, and September 11, 2029. No Rule 10b5-1 trading plan is reported in connection with this award.

Insider Trade Summary

Grant/Award: 2,530 shares

Grant/Award 1 txn

Insider STREICH JULIE K

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock F1	2,530	$0.00	$0.00

Holdings After Transaction: Common Stock — 2,530 shares (Direct)

Footnotes (1)

1. F1. Shares vest over a three-year vesting period with 1/3 of the shares vesting on 9/11/2027, 9/11/2028 and 9/11/2029.

Key Figures

Shares granted: 2,530 shares Price per share for grant: $0.00 per share Shares owned after transaction: 2,530 shares +1 more

4 metrics

Shares granted 2,530 shares Stock award to director Julie K. Streich on September 11, 2026

Price per share for grant $0.00 per share Reported for the 2,530-share stock award

Shares owned after transaction 2,530 shares Direct ownership by Julie K. Streich following the grant

Vesting schedule duration 3 years One-third of shares vesting in 2027, 2028, and 2029

Key Terms

vesting period, grant, Rule 10b5-1 trading plan

3 terms

vesting period financial

"Shares vest over a three-year vesting period with 1/3 of the shares vesting"

A vesting period is the set amount of time someone must wait before they fully own granted shares, stock options, or other equity tied to their work or an agreement; ownership increases gradually or in steps during that time. Investors care because vesting determines when insiders or employees can sell shares, which affects future supply of stock, company incentives and executive retention—think of it like unlocking ownership over installments rather than receiving it all at once.

grant financial

"reported that director Julie K. Streich received a grant of 2,530 shares"

Rule 10b5-1 trading plan regulatory

"No Rule 10b5-1 trading plan is reported in connection with this award"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did APOG director Julie K. Streich report?

Julie K. Streich reported receiving a grant of 2,530 shares of Apogee Enterprises common stock on September 11, 2026. The grant was an award with no cash price per share and increased her direct holdings to 2,530 shares.

How do the granted APOG shares vest for Julie K. Streich?

The 2,530 granted shares vest over a three-year vesting period. One-third of the shares vest on September 11, 2027, another third on September 11, 2028, and the final third on September 11, 2029.

What is Julie K. Streich’s APOG share ownership after this Form 4 transaction?

Following the reported grant, Julie K. Streich directly owns 2,530 shares of Apogee Enterprises common stock. All of these shares relate to the September 11, 2026 award subject to the stated vesting schedule.

Did Julie K. Streich buy or sell APOG shares for cash in this filing?

No. The Form 4 reports a grant of 2,530 shares of common stock as an award with a reported price per share of $0.00. It does not report any open-market purchases or sales for cash.

Was the APOG stock grant to Julie K. Streich under a Rule 10b5-1 plan?

The filing indicates that the Rule 10b5-1 trading plan affirmation box is not checked, so this 2,530-share grant is not reported as being made under a Rule 10b5-1 plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

STREICH JULIE K

(Last) (First) (Middle)

4400 W. 78TH STREET

SUITE 520

(Street)

MINNEAPOLIS MINNESOTA 55435

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
APOGEE ENTERPRISES, INC. [ APOG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/11/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/11/2026		A		2,530	A	$0	2,530(1)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares vest over a three-year vesting period with 1/3 of the shares vesting on 9/11/2027, 9/11/2028 and 9/11/2029.

Remarks:

	/s/Bryan A. Welp Attorney-in-Fact for Julie K. Streich	09/15/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)